<DOC>
	<DOCNO>NCT00821743</DOCNO>
	<brief_summary>Disturbance posture , gait balance usually appear several year Parkinson 's disease ( PD ) onset . These axial sign , generally resistant conventional drug non-drug treatment , generate loss autonomy traumatic complication . Improvement axial sign deep brain stimulation ( DBS ) pedunculo-pontin nucleus ( PPN ) describe small number patient . The objective present prospective monocentric pilot study determine optimal stimulation parameter PPN-DBS , evaluate long term tolerance effect PPN-DBS axial sign quality life five patient severe PD . The use detailed clinical rating scale quantitative computer-based gait analysis allow identify optimal stimulation parameter relevant clinical efficacy parameter , mandatory design comparative large-scale study .</brief_summary>
	<brief_title>Pedunculo-Pontin Nucleus ( PPN ) - Deep Brain Stimulation ( DBS ) Gait Balance Disturbance Parkinson 's Disease ( PPN-GAB-PARK Study )</brief_title>
	<detailed_description>Parkinson 's disease ( PD ) neurodegenerative disorder association akinesia , rigidity tremor , also so-called `` axial '' motor sign ( disturbance posture , gait balance ) usually appear several year disease evolution . These axial sign , generally resistant drug treatment deep brain stimulation ( DBS ) subthalamic nucleus ( STN ) , generate loss autonomy traumatic complication due frequent fall . An improvement axial sign DBS pedunculo-pontin nucleus ( PPN ) describe small number patient . Nevertheless , effect need confirm patient need complementary knowledge , include optimal stimulation modality . The primary objective current prospective monocentric pilot study determine optimal stimulation parameter ( site stimulation , frequency , amplitude ) PPN-DBS patient severe PD . Secondary objectives 1 ) confirm effect PPN-DBS disturbance posture , balance gait ; 2 ) evaluate long term tolerance technique ; 3 ) determine component gait improve PPN-DBS ; 4 ) evaluate unilateral versus bilateral stimulation ; 5 ) evaluate effect PPN-DBS PD symptom ; 6 ) determine impact PPN-DBS quality life . Five patient fulfil follow criterion , include : age 18 70 year , idiopathic PD 5 year , predominant axial motor sign ( disturbance gait balance , fall , freeze gait ) responsible disability daily live resistant optimal treatment . The DBS electrode ( model 3389 , Medtronic ) stereotactically implant bilaterally PPN , accord technique usually use STN-DBS , connect subcutaneously implant stimulator ( Kinetra , Medtronic ) . After surgery , study comprise two phase : 6-month phase dedicate optimisation stimulation parameter ( include systematic evaluation define parameter ) ; follow phase evaluation , compare , double-blind setting , 4 condition ( right unilateral , leave unilateral , bilateral stimulation ) . Efficacy PPN-DBS evaluate clinical rating scale quantify motor disturbance , cognitive function quality life , mean computer-based measure gait balance ( system Gaitrite Vicon ) . Expected result 1 ) improvement gait , postural balance disturbance , due PPN-DBS . 2 ) Identification optimal PPN-DBS parameter , improve axial PD symptom , allow abbreviate adjustment period , use default set parameter turn stimulator first time ; 3 ) Identification axial sign improve allow select patient could benefit PPN-DBS 4 ) The use diverse specific rating scale quantitative gait analysis allow determine relevant clinical criterion evaluate study . Thus , project allow obtain data ( selection criterion , relevant rating scale , optimal stimulation parameter ) mandatory construction comparative large-scale study , efficacy PPN-DBS confirm present study .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Severe idiopathic Parkinson 's disease ( stage Hoehn Yahr ≥ 3 ) . Disease duration ≥ 5 year . Predominant axial motor sign ( gait balance disturbance freeze gait , postural instability , fall ) disability daily life , define score UPDRS II 2 item 13 3 item 14 15 . Axial motor sign resistant optimal drug nondrug treatment , include physical therapy eventually STNDBS ( STNDBS ongoing least 1 year show efficacy axial motor sign ) . No significant abnormality brain MRI . Noninclusion criteria Patient nonaxial , doparesponsive motor sign indication first line STNDBS . In case absence efficacy STNDBS axial motor sign one year stimulation , PPNDBS may propose patient . Patient major cognitive disturbance define score Mattis DRS 130 ( 144 ) . Pregnant breastfeed woman . Patient contraindication general anaesthesia , contraindication surgery ( include disorder haemostasis , necessity anticoagulant antiaggregant drug ) , contraindication MRI . Patient present major depression , psychosis addiction six month precede inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>